Trial Profile
Effect and Safety of Benaglutide or Metformin in Patients With Simple Obesity Who Have Inadequate Weight Control :A Randomized, Open, Controlled and Single-site Clinical Trail
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Jul 2022
Price :
$35
*
At a glance
- Drugs Benaglutide (Primary) ; Metformin (Primary)
- Indications Obesity
- Focus Therapeutic Use
- 01 Jun 2022 Status changed from recruiting to completed as per the results published in the Experimental and Clinical Endocrinology and Diabetes
- 01 Jun 2022 Results published in the Experimental and Clinical Endocrinology and Diabetes
- 23 May 2019 Planned End Date changed from 1 Mar 2019 to 1 Dec 2019.